ZK824859
- Product NameZK824859
- CAS2254001-81-3
- CBNumberCB84668701
- MFC22H20F2N2O4
- MW414.4
- MDL NumberMFCD32200352
- MOL File2254001-81-3.mol
Chemical Properties
| solubility | DMSO: Soluble Methanol: Soluble |
ZK824859 Chemical Properties,Usage,Production
Uses
ZK824190 is an orally available and selective urokinase plasminogen activator (uPA) inhibitor as a potential treatment for multiple sclerosis. IC50s of 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively[1].in vivo
ZK824190 (2mg/kg; PO) exhibits a relatively high oral availability and a moderate half time (T1/2=2.8 h)[1].
| Animal Model: | Rats with experimental autoimmune encephalomyelitis (EAE) model[1] |
| Dosage: | 2mg/kg (Pharmacokinetic Analysis) |
| Administration: | PO |
| Result: | Oral availability F=55%; Cmax=0.64g/mL and AUC=2.2h*g/mL; T1/2=2.8 h. |
References
[1] Islam I, et al. Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis. Bioorg Med Chem Lett. 2018 Nov 1;28(20):3372-3375. DOI:10.1016/j.bmcl.2018.09.001ZK824859 Supplier
Global(47)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| +undefined-21-51877795 | ivan@atkchemical.com | 32996 | 60 | ||
| +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | 32430 | 58 | ||
| +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | 6377 | 58 | ||
| +1-781-999-5354; | support@targetmol.com | 38999 | 58 | ||
| 18143011203 | info@chemextension.com | 42052 | 58 | ||
| tp@aladdinsci.com | 50039 | 58 | |||
| +86-0086-13720134139 | orders@jknbiochem.com | 5214 | 58 | ||
| 13549236410 | sales@invivochem.cn | 6744 | 58 | ||
| 17316404525 17316404525 | 209533805@qq.com | 9790 | 58 | ||
| 400-821-026 | Sales@sangon.com | 6860 | 58 |